Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05635292 · ClinicalTrials.gov registry record · NA

Addressing Disability Effectively With Psychosocial Telemedicine

A NA study of Crohn Disease, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
715
Enrollment target
1
Study location

NCT05635292 is a NA study of Crohn Disease that has completed, run by University of Pennsylvania. The registered enrollment target is 715 participants, above the 195-participant average among 71 other Crohn Disease trials with a reported enrollment target (267% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05635292, a NA study of Crohn Disease, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
715 participants
Enrollment target
1
Study location

Study Summary

This multi-site study will be implemented at 5 gastroenterology practices to recruit 420 adults with IBD to complete a baseline survey and enroll those with higher scores on a validated IBD-disability scale into a randomized controlled trial of telehealth-delivered cognitive behavioral therapy with a licensed psychologist versus usual care. The investigators aim to lay the foundations that will shift the paradigm of IBD clinical practice towards a new horizon of holistic and equitable high-value care.

Conditions Studied

Interventions

  • BEHAVIORAL Tele-CBT

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 715 participants
Start Date 2023-02-15
Est. Completion 2024-01-31
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05635292

The ClinicalTrials.gov registry entry for NCT05635292 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 715 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 195-participant average among 71 other Crohn Disease trials with a reported enrollment target (267% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Crohn Disease appearing as the primary indexed condition, and to 1 intervention - of which Tele-CBT is the first listed.

NCT05635292 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05635292 about?

NCT05635292 is a clinical study titled "Addressing Disability Effectively With Psychosocial Telemedicine". This multi-site study will be implemented at 5 gastroenterology practices to recruit 420 adults with IBD to complete a baseline survey and enroll those with higher scores on a validated IBD-disability scale into a randomized controlled trial of telehealth-delivered cognitive behavioral therapy with ...

What is the current status of trial NCT05635292?

This trial is currently completed. It is a NA study. The enrollment target is 715 participants. The study started on 2023-02-15. Estimated completion is 2024-01-31.

What conditions does trial NCT05635292 study?

This clinical trial studies the following conditions: Crohn Disease.

What interventions are being tested in trial NCT05635292?

The interventions under investigation include: Tele-CBT (BEHAVIORAL).

Who is sponsoring clinical trial NCT05635292?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05635292 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Crohn Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.